BST-336

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBST-336
Drug Alias Namepeptide (BioSight)BST-336
ClassificationBiologics > Protein drugs > Recombinant polypeptideSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiosight Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosight Ltd
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A